CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial
E Osby, H Hagberg, S Kvaloy, L Teerenhovi, Harald Anderson, Eva Cavallin-Ståhl, H Holte, J Myhre, H Pertovaara, M Bjorkholm
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
Fingeravtryck
Fördjupa i forskningsämnen för ”CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial”. Tillsammans bildar de ett unikt fingeravtryck.